WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Cerrar esta carpetaAnnex
Ver el documentoClassification of topical corticosteroids
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Classification of topical corticosteroids

Hydrocortisone and betamethasone are examples of low- and high-potency topical corticosteroids. Topical corticosteroids have been ranked in terms of potency into four groups consisting of seven classes. Class I topical corticosteroids are the most potent and Class VII are the least potent. Efficacy and side-effects are greatest with the Class I ultra-high-potency preparations which should only be used for limited time periods (2-3 weeks). Representative preparations by group are listed in the table below. These groups may vary depending on the formulation and concentration and should be considered approximate. In general, ointments are more potent than creams or lotions. Potency is also increased when topical corticosteroids are used under occlusive dressings or in intertriginous areas.

Potency

Class

Topical corticosteroid

Formulation

Ultra high

I

Clobetasol propionate

Cream, 0.05%

   

Diflorasone diacetate

Ointment, 0.05%

High

II

Amcinonide

Ointment, 0.1%

   

Betamethasone dipropionate

Ointment, 0.05%

   

Desoximetasone

Cream or ointment, 0.025%

   

Fluocinonide

Cream, ointment or gel, 0.05%

   

Halcinonide

Cream, 0.1%

 

III

Betamethasone dipropionate

Cream, 0.05%

   

Betamethasone valerate

Ointment, 0.1%

   

Diflorasone diacetate

Cream, 0.05%

   

Triamcinolone acetonide

Ointment, 0.1%

Moderate

IV

Desoximetasone

Cream, 0.05%

   

Fluocinolone acetonide

Ointment, 0.025%

   

Fludroxycortide

Ointment, 0.05%

   

Hydrocortisone valerate

Ointment, 0.2%

   

Triamcinolone acetonide

Cream, 0.1%

 

V

Betamethasone dipropionate

Lotion, 0.02%

   

Betamethasone valerate

Cream, 0.1%

   

Fluocinolone acetonide

Cream, 0.025%

   

Fludroxycortide

Cream, 0.05%

   

Hydrocortisone butyrate

Cream, 0.1%

   

Hydrocortisone valerate

Cream, 0.2%

   

Triamcinolone acetonide

Lotion, 0.1%

Low

VI

Betamethasone valerate

Lotion, 0.05%

   

Desonide

Cream, 0.05%

   

Fluocinolone acetonide

Solution, 0.01%

 

VII

Dexamethasone sodium phosphate

Cream, 0.1%

   

Hydrocortisone acetate

Cream, 1%

   

Methylprednisolone acetate

Cream, 0.25%

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012